Journal of Cardiovascular Pharmacology
Empagliflozin Reduces Post-Myocardial Infarction Inflammation via BDH1/β-Hydroxybutyrate-Mediated NF-κB Modulation in Macrophages and the Heart
Experiments in animalsInterventions
Papers by Xiangyong Kong
1 result